US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Genflow Biosciences Plc

0.0300

0.0000

Volume:- -

Turnover:- -

Market Cap:14.81M

PE:- -

High:0.0300

Open:0.0300

Low:0.0300

Close:0.0300

52wk High:0.0645

52wk Low:0.0100

Shares:493.55M

Float Shares:453.55M

Volume Ratio:1.45

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:-648.46%

ROA:-123.70%

PB:-36.15

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Genflow Biosciences Plc

Exchange:

OTCQB

Establishment Date:

2020

Employees:

5

Office Location:

6 Heddon Street,London,Greater London,United Kingdom

Website:

http://genflowbio.com

Zip Code:

W1B 4BT

Phone:

- -

Fax:

- -

Introduction:

Genflow Biosciences plc, together with its subsidiaries, operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. Genflow Biosciences plc was incorporated in 2021 and is headquartered in London, the United Kingdom.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GENFF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GENFF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GENFF\",,,,,undefined,":{"symbol":"GENFF","market":"US","secType":"STK","nameCN":"Genflow Biosciences Plc","latestPrice":0.03,"timestamp":1771621200000,"preClose":0.03,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":453547942,"shares":493547942,"eps":0,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-20 16:00:00 EST Delay","open":0.03,"high":0.03,"low":0.03,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":0,"adr":0,"exchange":"OTCQB","adjPreClose":0.03,"volumeRatio":1.4546684746466443},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GENFF\",,,,,undefined,":{"symbol":"GENFF","floatShares":453547942,"roa":"-123.70%","roe":"-648.46%","lyrEps":0,"volumeRatio":1.4546684746466443,"shares":493547942,"dividePrice":0,"high":0.03,"amplitude":0,"preClose":0.03,"low":0.03,"week52Low":0.01,"pbRate":"-36.15","psRate":"-20.03","week52High":0.0645,"institutionHeld":0,"latestPrice":0.03,"eps":0,"divideRate":0,"volume":0,"delay":15,"open":0.03,"prevYearClose":0.036,"prevWeekClose":0.03,"prevMonthClose":0.0384,"prevQuarterClose":0.036,"fiveDayClose":0.03,"twentyDayClose":0.0384,"sixtyDayClose":0.0199},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GENFF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-07","symbol":"GENFF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GENFF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GENFF\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1763803753,"yearFounded":2020,"employeeNum":5,"address":"6 Heddon Street,London,Greater London,United Kingdom","zipCode":"W1B 4BT"},"stockCompanyDetail":{"websiteUrl":"http://genflowbio.com","description":"Genflow Biosciences plc, together with its subsidiaries, operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. Genflow Biosciences plc was incorporated in 2021 and is headquartered in London, the United Kingdom.","exchange":"OTCQB","name":"Genflow Biosciences Plc","nameEN":"Genflow Biosciences Plc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GENFF\",market:\"US\",,,undefined,":null}}